Global Oral Vaccines Market Growth 2023-2029

Global Oral Vaccines Market Growth 2023-2029

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

LPI (LP Information)' newest research report, the “Oral Vaccines Industry Forecast” looks at past sales and reviews total world Oral Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Oral Vaccines sales for 2023 through 2029. With Oral Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Oral Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Oral Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Vaccines.

The global Oral Vaccines market size is projected to grow from US$ 2420.2 million in 2022 to US$ 3284.9 million in 2029; it is expected to grow at a CAGR of 3284.9 from 2023 to 2029.

The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine is about 94%.

Middle East and Africa is the largest consumption place, with a consumption market share nearly 54%. Following Middle East and Africa, Asia-Pacific is the second largest consumption place with the consumption market share of 31%.

Market competition is intense. Merck, GSK and Sanofi, etc. are the leaders of the industry, with about 78% market shares.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Vaccines market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

Rotavirus Vaccine

Cholera Vaccine

Oral Polio Vaccine

Segmentation by application

Public

Private

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Merck

GSK

Sanofi

Lanzhou Institute

Serum Institute

Valneva

Shanghai United Cell

Bibcol

PaxVax

Vabiotech

Tiantan Biological

EuBiologics

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Oral Vaccines market?

What factors are driving Oral Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Oral Vaccines market opportunities vary by end market size?

How does Oral Vaccines break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.